12-8606849-C-T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020661.4(AICDA):c.156+16G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.49 in 1,613,040 control chromosomes in the GnomAD database, including 201,129 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_020661.4 intron
Scores
Clinical Significance
Conservation
Publications
- hyper-IgM syndrome type 2Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AICDA | NM_020661.4 | c.156+16G>A | intron_variant | Intron 2 of 4 | ENST00000229335.11 | NP_065712.1 | ||
| AICDA | NM_001330343.2 | c.156+16G>A | intron_variant | Intron 2 of 4 | NP_001317272.1 | |||
| AICDA | NM_001410970.1 | c.156+16G>A | intron_variant | Intron 2 of 3 | NP_001397899.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.559 AC: 84882AN: 151946Hom.: 25146 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.526 AC: 130961AN: 249030 AF XY: 0.518 show subpopulations
GnomAD4 exome AF: 0.483 AC: 704926AN: 1460976Hom.: 175938 Cov.: 43 AF XY: 0.483 AC XY: 351096AN XY: 726854 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.559 AC: 84987AN: 152064Hom.: 25191 Cov.: 32 AF XY: 0.566 AC XY: 42087AN XY: 74308 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hyper-IgM syndrome type 2 Benign:4
- -
- -
- -
- -
not specified Benign:3
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
This variant is classified as Benign based on local population frequency. This variant was detected in 66% of patients studied by a panel of primary immunodeficiencies. Number of patients: 63. Only high quality variants are reported. -
- -
not provided Benign:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at